BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Immunology Podcast - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.immunologypodcast.com
X-WR-CALDESC:Events for The Immunology Podcast
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250821T160000
DTEND;TZID=America/New_York:20250821T170000
DTSTAMP:20260416T055310
CREATED:20250702T180430Z
LAST-MODIFIED:20250702T180430Z
UID:6212-1755792000-1755795600@www.immunologypodcast.com
SUMMARY:The Immunology Podcast Presents: The Evolution of mRNA-Based Dendritic Cell Cancer Vaccines
DESCRIPTION:Join us live from the IUIS 2025 Congress in Vienna for a special episode of the Immunology Podcast featuring Dr. Zwi Berneman\, a leader in cancer immunotherapy. In this special recording\, hosts Drs. Brenda Raud and Jason Goldsmith will guide Dr. Berneman through the two-decade evolution of mRNA-based dendritic cell vaccination\, highlighting its applications in both hematologic malignancies like acute myeloid leukemia and solid tumors such as mesothelioma and glioblastoma. Together\, they will explore the journey of scientific discovery\, clinical breakthroughs\, and real-world impact\, as Dr. Berneman reflects on the lessons learned and what the future holds for personalized immunotherapy. \nDate: Thursday\, August 21\, 2025\nTime: 4:00 – 5:00 p.m.\nLocation: Austria Center Vienna\, Hall M
URL:https://www.immunologypodcast.com/upcoming-guests/the-immunology-podcast-presents-the-evolution-of-mrna-based-dendritic-cell-cancer-vaccines
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/07/Photo_Zwi-BERNEMAN-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251007
DTEND;VALUE=DATE:20251008
DTSTAMP:20260416T055310
CREATED:20250826T211022Z
LAST-MODIFIED:20250826T211022Z
UID:6284-1759795200-1759881599@www.immunologypodcast.com
SUMMARY:Dr. Robin Orozco
DESCRIPTION:Dr. Robin Orozco is an Assistant Professor at the University of Kansas. Her lab uses a variety of transgenic murine models to dissect the molecular and cellular mechanisms a particular mutation is impacting viral replication\, immune cell function\, and viral associated pathologies. Currently\, they study the contribution of the common pro-autoimmune allele of PTPN22 (rs2476601) in regulating the balance between protection and pathology during virus infection.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-robin-orozco
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/08/Robin-Orozco-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251021
DTEND;VALUE=DATE:20251022
DTSTAMP:20260416T055310
CREATED:20251007T173951Z
LAST-MODIFIED:20251007T173951Z
UID:6322-1761004800-1761091199@www.immunologypodcast.com
SUMMARY:Dr. Matteo Iannacone
DESCRIPTION:Dr. Matteo Iannacone is a Professor and Group Leader at the San Raffaele Scientific Institute. The Iannacone lab’s work centers on understanding how immune responses are orchestrated within local tissue niches. Their goal is to uncover novel principles of tissue immunity and leverage them for more precise immunotherapeutic strategies.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-matteo-iannacone
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/10/Matteo-Iannacone-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251104
DTEND;VALUE=DATE:20251105
DTSTAMP:20260416T055310
CREATED:20251021T155701Z
LAST-MODIFIED:20251021T155701Z
UID:6339-1762214400-1762300799@www.immunologypodcast.com
SUMMARY:Dr. Camila Coelho
DESCRIPTION:Dr. Camila Coelho is an Assistant Professor at the Icahn School of Medicine at Mount Sinai\, where her group studies memory B cell responses to vaccines against emerging pathogens and novel vaccine platforms. They strive to perform impactful research that can help inform public health policies and vaccine (re)design.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-camila-coelho
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/10/Camila-Coelho-headshot.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251202
DTEND;VALUE=DATE:20251203
DTSTAMP:20260416T055310
CREATED:20251124T195333Z
LAST-MODIFIED:20251124T195333Z
UID:6363-1764633600-1764719999@www.immunologypodcast.com
SUMMARY:Dr. Ana Anderson
DESCRIPTION:Dr. Ana Anderson is the Albert H. Coons Professor of Neurology at Harvard Medical School. Research in the Anderson Laboratory focuses on understanding the pathways and mechanisms that regulate the T cell response in chronic disease\, particularly in cancer. Specific areas of investigation are examination of the role of co-inhibitory/immune checkpoint receptor pathways in regulating effector and regulatory T cells in cancer and defining the distinct effector T cell states present in tumor tissue.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-ana-anderson
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2025/11/Ana-Anderson-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260127
DTEND;VALUE=DATE:20260128
DTSTAMP:20260416T055310
CREATED:20260126T201253Z
LAST-MODIFIED:20260126T201253Z
UID:6402-1769472000-1769558399@www.immunologypodcast.com
SUMMARY:Dr. Rafi Ahmed
DESCRIPTION:Dr. Rafi Ahmed is a world-renowned immunologist whose work during the past decade has been highly influential in shaping our current understanding of memory T cell differentiation and anti-viral T and B cell immunity. A major area of focus is identifying cellular molecules that regulate the generation and maintenance of CD8 and CD4 T cell and humoral immunity. Another is understanding humoral memory development and maintenance.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-rafi-ahmed
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2026/01/Rafi-Ahmed-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260210
DTEND;VALUE=DATE:20260211
DTSTAMP:20260416T055310
CREATED:20260204T233935Z
LAST-MODIFIED:20260204T233935Z
UID:6425-1770681600-1770767999@www.immunologypodcast.com
SUMMARY:Dr. Sharon Lewin
DESCRIPTION:Dr. Sharon Lewin is the Director of the Doherty Institute for Infection and Immunity. She is an infectious diseases physician and basic scientist\, who is internationally renowned for her research into all aspects of HIV disease and specifically in strategies to achieve an HIV cure.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-sharon-lewin
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2026/02/Sharon-Lewin-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260225
DTSTAMP:20260416T055310
CREATED:20260204T234332Z
LAST-MODIFIED:20260204T234332Z
UID:6429-1771891200-1771977599@www.immunologypodcast.com
SUMMARY:Dr. Ido Amit
DESCRIPTION:Dr. Ido Amit is a Principal Investigator and Eden and Steven Romick Professorial Chair at the Weizmann Institute. His lab pioneered single cell genomic technologies and their application to characterize the immune system. Dr. Amit’s research answers some of the most fundamental questions in immunology which are being translated into innovate new targets for immunotherapy in autoimmune diseases\, neurodegeneration and cancer.
URL:https://www.immunologypodcast.com/upcoming-guests/dr-ido-amit
ATTACH;FMTTYPE=image/jpeg:https://www.immunologypodcast.com/wp-content/uploads/2026/02/Ido-Amit-420-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260417T110000
DTEND;TZID=America/New_York:20260417T120000
DTSTAMP:20260416T055310
CREATED:20260302T165757Z
LAST-MODIFIED:20260302T165757Z
UID:6457-1776423600-1776427200@www.immunologypodcast.com
SUMMARY:Live Show: Emerging Immunotherapies for Solid Tumors
DESCRIPTION:Join the Immunology Podcast for a live recording on emerging immunotherapies for solid tumors at IMMUNOLOGY2026™. Hosts Brenda Raud and Jason Goldsmith will be joined by Dr. Charles Sentman\, Director of the Center for Synthetic Immunity at Dartmouth College\, and Dr. Giulia Escobar\, Director of Pre-Clinical Research at Massachusetts General Hospital. Together\, they’ll explore new strategies aimed at overcoming the unique challenges of treating solid tumors\, from engineering more effective immune cells to navigating the tumor microenvironment. The discussion will highlight recent advances in preclinical and translational research and what they could mean for the future of cancer immunotherapy. \nDate: Friday\, April 17\, 2026\nTime: 11:00 – 12:00 pm\nLocation: Thomas M. Menino Convention & Exhibition Center\, Room 157AB
URL:https://www.immunologypodcast.com/upcoming-guests/live-show-emerging-immunotherapies-for-solid-tumors
ATTACH;FMTTYPE=image/png:https://www.immunologypodcast.com/wp-content/uploads/2026/03/Charles-Sentman-and-Giulia-Escobar.png
END:VEVENT
END:VCALENDAR